Published Studies Related to Kytril Injection (Granisetron Injection)
Well-designed clinical trials related to Kytril Injection (Granisetron Injection)
Comparison of an extended-release formulation of granisetron (APF530) versus
palonosetron for the prevention of chemotherapy-induced nausea and vomiting
associated with moderately or highly emetogenic chemotherapy: results of a
prospective, randomized, double-blind, noninferiority phase 3 trial. [2015]
Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population. [2011.03]
Efficacy and tolerability of transdermal granisetron for the control of
chemotherapy-induced nausea and vomiting associated with moderately and highly
emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study. [2011]
Dexamethasone with either granisetron or ondansetron for postoperative nausea and vomiting in laparoscopic surgery. [2010.02]
Reduction of severity of pruritus after elective caesarean section under spinal anaesthesia with subarachnoid morphine: a randomised comparison of prophylactic granisetron and ondansetron. [2010.01]
Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron. [2010.01]
Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with
granisetron. [2010]
Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting. [2009.12]
Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies. [2009.11]
Combination therapy in the prevention of PONV after strabismus surgery in children: granisetron, ondansetron, midazolam with dexamethasone. [2009.10]
Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial. [2009.07]
A randomized, double-blinded comparison of ondansetron, granisetron, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. [2009.07]
Does granisetron eliminate the gag reflex? A crossover, double-blind, placebo-controlled pilot study. [2009.03]
Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron. [2008.11.21]
Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron. [2008.08.21]
Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials. [2007.12]
The effectiveness of inhalation isopropyl alcohol vs. granisetron for the prevention of postoperative nausea and vomiting. [2007.12]
Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials. [2007.12]
Intramuscular injection of granisetron into the masseter muscle increases the pressure pain threshold in healthy participants and patients with localized myalgia. [2007.07]
Granisetron versus ondansetron treatment for breakthrough postoperative nausea and vomiting after prophylactic ondansetron failure: a pilot study. [2007.06]
Prevention of postoperative nausea and vomiting in patients undergoing laparoscopic bariatric surgery--granisetron alone vs granisetron combined with dexamethasone/droperidol. [2007.06]
Superior anti-emetic efficacy of granisetron-dexamethasone combination in children undergoing middle ear surgery. [2007.05]
The prophylactic granisetron does not prevent postdelivery nausea and vomiting during elective cesarean delivery under spinal anesthesia. [2007.03]
Does ondansetron or granisetron prevent subarachnoid morphine-induced pruritus after cesarean delivery? [2007.02]
Control of shivering during regional anaesthesia: prophylactic ketamine and granisetron. [2007.01]
A comparison of cyclizine and granisetron alone and in combination for the prevention of postoperative nausea and vomiting. [2006.11]
Rapid determination of granisetron in human plasma by liquid chromatography coupled to tandem mass spectrometry and its application to bioequivalence study. [2006.10.11]
The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery. [2006.05]
Prevention of postoperative nausea and vomiting with granisetron and dolasetron in relation to CYP2D6 genotype. [2006.04]
Age-related differences in metoclopramide requirement for pain on injection of propofol. [2006]
Comparative clinical study of the anti-emetic effects of oral ramosetron and injected granisetron in patients with malignant glioma undergoing ACNU chemotherapy. [2005.06]
Benefits and risks of granisetron versus ramosetron for nausea and vomiting after breast surgery: a randomized, double-blinded, placebo-controlled trial. [2004.07]
Efficacy of prophylactic intravenous granisetron in postoperative emesis in adults. [2004]
Pain on injection of propofol: the effect of granisetron pretreatment. [2003.03]
[Clinical observation of granisetron in preventing postoperative nausea and vomiting following supratentorial craniotomy] [2002.12.28]
Treatment of vomiting after paediatric strabismus surgery with granisetron, droperidol, and metoclopramide. [2002.09]
Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children. [2001.06]
Comparison of granisetron, droperidol, and metoclopramide for prevention of postoperative vomiting in children with a history of motion sickness undergoing tonsillectomy. [2001.03]
Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation. [2001]
Immediate effects of the serotonin antagonist granisetron on temporomandibular joint pain in patients with systemic inflammatory disorders. [2000.12.22]
Granisetron/dexamethasone combination for the prevention of postoperative nausea and vomiting after thyroidectomy. [2000.06]
Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study. [2000.04]
Comparison of granisetron, ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin. [2000.02]
Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle. [2000.02]
Granisetron/dexamethasone combination for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. [2000.01]
[Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron] [1999.03]
Combination of granisetron and droperidol for the prevention of vomiting after paediatric strabismus surgery. [1999]
A comparative study of administration methods of granisetron injection used to treat nausea/vomiting induced by cancer chemotherapy without cisplatin in tumors of hematopoietic organs. Keihanshin Study Group of Hematological Malignancies. [1999]
Oral granisetron as prophylaxis for nausea and vomiting during fluorescein angiography. A multicentre, double-blind, randomised, parallel group, placebo-controlled study. [1998.12]
[Comparison of crossing-over between 30-minute drip infusion vs 30-second injection of granisetron for nausea and vomitting with cisplatin] [1998.11]
A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin. [1998.10]
[Comparison of antiemetic efficacy of granisetron as premedication versus combination therapy of granisetron] [1998.10]
[Efficacy and safety of two methods of administration of granisetron injection for nausea and vomiting induced by chemotherapy for tumors in hematopoietic organs--a randomized crossover comparison between intravenous drip infusion and intravenous bolus injection] [1998.09]
Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis. [1998.07]
Prophylactic antiemetic therapy with granisetron-droperidol combination in patients undergoing laparoscopic cholecystectomy. [1998.06]
Efficacy of thoracic epidural analgesia following laparoscopic cholecystectomy. [1998.05]
Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study. [1998.02]
Comparison of granisetron and droperidol in the prevention of vomiting after strabismus surgery or tonsillectomy in children. [1998]
Efficacy of intravenous granisetron to control nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. [1998]
A double-blind, parallel-group, placebo-controlled, dose-ranging, multicenter study of intravenous granisetron in the treatment of postoperative nausea and vomiting in patients undergoing surgery with general anesthesia. [1997.12]
[Comparison of effects between single vs five-day injection of granisetron for combination chemotherapy with cisplatin and 5-fluorouracil for head and neck cancer] [1997.07]
Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults. [1997.05.15]
Granisetron reduces the incidence and severity of nausea and vomiting after laparoscopic cholecystectomy. [1997.04]
Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis. [1997.01]
Single-dose i.v. granisetron in the prevention of postoperative nausea and vomiting. [1996.04]
A pilot study to evaluate the cost-effectiveness of ondansetron and granisetron in fractionated total body irradiation. [1996]
Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis. [1995.07]
[Antiemetic efficacy of granisetron in the treatment of pediatric cancer--(1). Clinical evaluation of granisetron at a dose of 40 micrograms/kg] [1993.11]
A dose-finding study of granisetron, a novel antiemetic, in patients receiving cytostatic chemotherapy. The Granisetron Study Group. [1993]
Well-designed clinical trials possibly related to Kytril Injection (Granisetron Injection)
Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and
vomiting following high-dose cisplatin in Chinese patients: a randomized,
double-blind, placebo-controlled phase III trial. [2014]
Selective serotonin 3 receptor antagonist treatment for schizophrenia:
meta-analysis and systematic review. [2014]
Prevention of delayed nausea: a University of Rochester Cancer Center Community
Clinical Oncology Program study of patients receiving chemotherapy. [2012]
A network meta-analysis on the efficacy of serotonin type 3 receptor antagonists
used in adults during the first 24 hours for postoperative nausea and vomiting
prophylaxis. [2012]
Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients. [2011.09]
Antiemetic prophylaxis in thyroid surgery: a randomized, double-blind comparison of three 5-HT3 agents. [2011.06]
Antiemetic activity of megestrol acetate in patients receiving chemotherapy. [2011.05]
Current review of ramosetron in the prevention of postoperative nausea and
vomiting. [2011]
Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin. [2010.11]
The influence of ondansetron on the analgesic effect of acetaminophen after laparoscopic hysterectomy. [2010.06]
Hypothalamic glutamate levels following serotonergic stimulation: a pilot study using 7-Tesla magnetic resonance spectroscopy in healthy volunteers. [2010.04.16]
A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting. [2010.04]
[Electroacupuncture at Zusanli (ST 36) for treatment of nausea and vomiting caused by the chemotherapy of the malignant tumor: a multicentral randomized controlled trial] [2009.12]
Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial. [2009.02]
Role of 5-hydroxytryptamine mechanisms in mediating the effects of small intestinal glucose on blood pressure and antropyloroduodenal motility in older subjects. [2007.10]
Acute gastroenteritis in children: role of anti-emetic medication for gastroenteritis-related vomiting. [2007]
[Treatment of chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists] [2006.12.01]
A randomized blinded study of the incidence of postoperative nausea and vomiting in women after major gynecologic laparoscopic surgery. [2006.09]
Drugs for preventing postoperative nausea and vomiting. [2006.07.19]
Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. [2006.04]
Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma. [2006.03.02]
[Nasea injection in the prophylaxis of gastrointestinal reaction induced by chemotherapeutic agents] [2000.01]
Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin. [1998.01]
Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy. [1996.06]
Intracolonic injection of glycerol: a model for abdominal pain in irritable bowel syndrome? [1996.02]
Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin. [1996.01]
Other research related to Kytril Injection (Granisetron Injection)
Can granisetron injection used as primary prophylaxis improve the control of
nausea and vomiting with low- emetogenic chemotherapy? [2013]
Influence of intramuscular granisetron on experimentally induced muscle pain by
acidic saline. [2013]
Comparison of the efficacy of ondansetron and granisetron to prevent
postoperative nausea and vomiting after laparoscopic cholecystectomy: a
systematic review and meta-analysis. [2013]
Granisetron as an add-on to risperidone for treatment of negative symptoms in
patients with stable schizophrenia: randomized double-blind placebo-controlled
study. [2013]
A randomized controlled non-inferiority study comparing the antiemetic effect
between intravenous granisetron and oral azasetron based on estimated 5-HT3
receptor occupancy. [2012]
Pharmacokinetics and repolarization effects of intravenous and transdermal
granisetron. [2012]
|
